References
- Robertson CM, Watt MJ, Dinu IA. Outcomes for the extremely premature infant: what is new? And where are we going? Pediatr Neurol 2009;40:189–96
- Maitre NL, Stark AR. Neuroprotection for premature infants? Another perspective on caffeine. JAMA 2012;307:304–5
- Erenberg A, Leff RD, Haack DG, et al. Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study. Pharmacotherapy 2000;20:644–52
- Gaytan SP, Pasaro R. Neonatal caffeine treatment up-regulates adenosine receptors in brainstem and hypothalamic cardio-respiratory related nuclei of rat pups. Exp Neurol 2012;237:247–59
- Cui H, Ding Y, Yu Y, Yang L. Changes of amplitude integration electroencephalogram (aEEG) in different maturity preterm infant. Childs Nerv Syst 2013;29:1169–76
- Herbertz S, Pulzer F, Gebauer C, et al. The effect of maturation and sedation on amplitude-integrated electroencephalogram of the preterm neonate: results of a prospective study. Acta Paediatr 2006;95:1394–9
- Soubasi V, Mitsakis K, Nakas CT, et al. The influence of extrauterine life on the aEEG maturation in normal preterm infants. Early Hum Dev 2009;85:761–5
- Clancy RR, Dicker L, Cho S, et al. Agreement between long-term neonatal background classification by conventional and amplitude-integrated EEG. J Clin Neurophysiol 2011;28:1–9
- Ballard JL, Khoury JC, Wedig K, et al. New Ballard Score, expanded to include extremely premature infants. J Pediatr 1991;119:417–23
- Schmidt B, Roberts RS, Davis P, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 2007;357:1893–902
- Brazelton TB. Assessment of the infant at risk. Clin Obstet Gynecol 1973;16:361–75
- Thornberg E, Thiringer K. Normal pattern of the cerebral function monitor trace in term and preterm neonates. Acta Paediatr Scand 1990;79:20–5
- Hellstrom-Westas L. Continuous electroencephalography monitoring of the preterm infant. Clin Perinatol 2006;33:633–47
- Burdjalov VF, Baumgart S, Spitzer AR. Cerebral function monitoring: a new scoring system for the evaluation of brain maturation in neonates. Pediatrics 2003;112:855–61
- Nunes ML, da Costa JC, Taufer L, da Silveira CM. [Value of EEG in the characterization and prognosis of neurological diseases in premature infants]. Arq Neuropsiquiatr 1995;53:625–30
- Shen HY, Li T, Boison D. A novel mouse model for sudden unexpected death in epilepsy (SUDEP): role of impaired adenosine clearance. Epilepsia 2010;51:465–8
- Fredholm BB, Battig K, Holmen J, et al. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999;51:83–133
- Chan SL, Mayne M, Holden CP, et al. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. J Biol Chem 2000;275:18195–200
- Connolly S, Kingsbury TJ. Caffeine modulates CREB-dependent gene expression in developing cortical neurons. Biochem Biophys Res Commun 2010;397:152–6
- Supcun S, Kutz P, Pielemeier W, Roll C. Caffeine increases cerebral cortical activity in preterm infants. J Pediatr 2010;156:490–1
- Barry RJ, Clarke AR, Johnstone SJ, et al. Caffeine effects on resting-state arousal in children. Int J Psychophysiol 2009;73:355–61
- Curzi-Dascalova L, Aujard Y, Gaultier C, Rajguru M. Sleep organization is unaffected by caffeine in premature infants. J Pediatr 2002;140:766–71
- Soloveychik V, Bin-Nun A, Ionchev A, et al. Acute hemodynamic effects of caffeine administration in premature infants. J Perinatol 2009;29:205–8
- Kassim Z, Greenough A, Rafferty GF. Effect of caffeine on respiratory muscle strength and lung function in prematurely born, ventilated infants. Eur J Pediatr 2009;168:1491–5
- Doyle LW, Schmidt B, Anderson PJ, et al. Reduction in developmental coordination disorder with neonatal caffeine therapy. J Pediatr 2014;165:356–9